Literature DB >> 23871219

High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells.

Norifumi Iijima1, Edward C Goodwin, Daniel Dimaio, Akiko Iwasaki.   

Abstract

High-risk human papillomaviruses (HPVs) cause a variety of malignancies of the mucosal epithelium. However, the local immune evasion strategies used by HPV-transformed cells remain unclear. Here, we examined the effect of HPV-positive cancer cells on human peripheral blood monocytes, which are precursors of Langerhans cells, key antigen-presenting cells in the squamous epithelium. HPV-positive cervical cancer cells and HPV-E6 expressing cells inhibited monocyte differentiation to Langerhans cells in a contact-dependent manner. Unlike Langerhans cells, monocytes that differentiated in the presence of HPV16 E6-expressing cells exhibited high levels of endocytic activity. Our results suggest that cells infected by high-risk HPV evade immune surveillance by blocking the differentiation of monocytes into competent antigen presenting cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Dendritic cell; Immune evasion; Monocytes

Mesh:

Substances:

Year:  2013        PMID: 23871219      PMCID: PMC3755085          DOI: 10.1016/j.virol.2013.06.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Langerhans cells renew in the skin throughout life under steady-state conditions.

Authors:  Miriam Merad; Markus G Manz; Holger Karsunky; Amy Wagers; Wendy Peters; Israel Charo; Irving L Weissman; Jason G Cyster; Edgar G Engleman
Journal:  Nat Immunol       Date:  2002-11-04       Impact factor: 25.606

2.  Selective suppression of monocyte chemoattractant protein-1 expression by human papillomavirus E6 and E7 oncoproteins in human cervical epithelial and epidermal cells.

Authors:  Kerstin Kleine-Lowinski; James G Rheinwald; Raina N Fichorova; Deborah J Anderson; John Basile; Karl Münger; Christine M Daly; Frank Rösl; Barrett J Rollins
Journal:  Int J Cancer       Date:  2003-11-10       Impact factor: 7.396

3.  Evaluation of Langerhans' cells in human papillomavirus-associated squamous intraepithelial lesions of the uterine cervix.

Authors:  N S Uchimura; J C L Ribalta; J Focchi; M J Simões; T T Uchimura; E S Silva
Journal:  Clin Exp Obstet Gynecol       Date:  2004       Impact factor: 0.146

4.  Viral MHC class I inhibition evades CD8+ T-cell effector responses in vivo but not CD8+ T-cell priming.

Authors:  Maria D Gainey; Joshua G Rivenbark; Hyelim Cho; Liping Yang; Wayne M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-29       Impact factor: 11.205

5.  Rapid induction of senescence in human cervical carcinoma cells.

Authors:  E C Goodwin; E Yang; C J Lee; H W Lee; D DiMaio; E S Hwang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

6.  Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

Authors:  E C Goodwin; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

7.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.

Authors:  Rosa Anna DeFilippis; Edward C Goodwin; Lingling Wu; Daniel DiMaio
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Transforming growth factor beta1, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes into dendritic Langerhans cells.

Authors:  F Geissmann; C Prost; J P Monnet; M Dy; N Brousse; O Hermine
Journal:  J Exp Med       Date:  1998-03-16       Impact factor: 14.307

10.  Depletion of Langerhans cells in human papillomavirus type 16-infected skin is associated with E6-mediated down regulation of E-cadherin.

Authors:  Kate Matthews; Cheng Mee Leong; Lindsay Baxter; Emma Inglis; Kankatsu Yun; B Thomas Bäckström; John Doorbar; Merilyn Hibma
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more
  11 in total

1.  Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.

Authors:  Diane M Da Silva; Carly A Movius; Adam B Raff; Heike E Brand; Joseph G Skeate; Michael K Wong; W Martin Kast
Journal:  Virology       Date:  2014-02-17       Impact factor: 3.616

2.  Human papilloma virus early proteins E6 (HPV16/18-E6) and the cell cycle marker P16 (INK4a) are useful prognostic markers in uterine cervical carcinomas in Qassim Region--Saudi Arabia.

Authors:  O M Omran; M AlSheeha
Journal:  Pathol Oncol Res       Date:  2014-06-13       Impact factor: 3.201

3.  Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer.

Authors:  Dan Song; Hong Li; Haibo Li; Jianrong Dai
Journal:  Oncol Lett       Date:  2015-05-29       Impact factor: 2.967

4.  An epithelial organoid model with Langerhans cells for assessing virus-host interactions.

Authors:  Robert Jackson; Statton Eade; Ingeborg Zehbe
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

5.  E6 viral protein ratio correlates with outcomes in human papillomavirus related oropharyngeal cancer.

Authors:  Angela Hong; Xiaoying Zhang; Deanna Jones; Mei Zhang; C Soon Lee; J Guy Lyons; Anne-Sophie Veillard; Barbara Rose
Journal:  Cancer Biol Ther       Date:  2015-11-17       Impact factor: 4.742

6.  The HPV16 E7 Oncoprotein Disrupts Dendritic Cell Function and Induces the Systemic Expansion of CD11b(+)Gr1(+) Cells in a Transgenic Mouse Model.

Authors:  Gabriela Damian-Morales; Nicolás Serafín-Higuera; Mario Adán Moreno-Eutimio; Enoc M Cortés-Malagón; José Bonilla-Delgado; Genaro Rodríguez-Uribe; Rodolfo Ocadiz-Delgado; Paul F Lambert; Patricio Gariglio
Journal:  Biomed Res Int       Date:  2016-07-11       Impact factor: 3.411

Review 7.  Modulation of antigen presenting cell functions during chronic HPV infection.

Authors:  Abate Assefa Bashaw; Graham R Leggatt; Janin Chandra; Zewen K Tuong; Ian H Frazer
Journal:  Papillomavirus Res       Date:  2017-08-18

Review 8.  The interplay between the vaginal microbiome and innate immunity in the focus of predictive, preventive, and personalized medical approach to combat HPV-induced cervical cancer.

Authors:  Erik Kudela; Alena Liskova; Marek Samec; Lenka Koklesova; Veronika Holubekova; Tomas Rokos; Erik Kozubik; Terezia Pribulova; Kevin Zhai; Dietrich Busselberg; Peter Kubatka; Kamil Biringer
Journal:  EPMA J       Date:  2021-05-18       Impact factor: 8.836

9.  Epithelium Expressing the E7 Oncoprotein of HPV16 Attracts Immune-Modulatory Dendritic Cells to the Skin and Suppresses Their Antigen-Processing Capacity.

Authors:  Janin Chandra; Yan Miao; Natasha Romoff; Ian H Frazer
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

10.  Comment on 'The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study'.

Authors:  Bernard Friedenson
Journal:  Br J Cancer       Date:  2016-07-26       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.